DRKS00021814尚未招募不适用
Examination of the response to rewards in people with alcohol consumption disorder by measuring their eye movements
Zentralinstitut für Seelische Gesundheit Mannheim0 个研究点目标入组 50 人开始时间: 2020年5月27日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Subjects with alcohol use disorder:
- •Men and women between the ages of 18 and 65
- •Fulfillment of at least 2 and maximum of 5 of the criteria for an alcohol use disorder (Alcohol Use Disorder) according to DSM-V, corresponding to a mild to moderate alcohol consumption disorder
- •Adequate ability to communicate with the examiner to answer questions verbally and in writing
- •Ability to consent after detailed written clarification (Fully Informed Consent)
- •Normal or correctable (with contact lenses) poor eyesight
- •abstinence from alcohol on Test day
- •Healthy subjects in the control group:
- •Men and women between the ages of 18 and 65
- •Alcohol consumption on a maximum of 5 days a week, a maximum of 12 g each alcohol per day for women (equivalent to 0.3 l beer; 0.125 l wine) and 24 g alcohol per day for men (corresponding to 0.6 l beer; 0.25 l wine)
- •Adequate ability to communicate with the examiner to answer questions verbally and in writing
- •Ability to consent after detailed written clarification (Fully Informed Consent)
- •Normal or correctable (with contact lenses) poor eyesight
- •abstinence from alcohol on test day
排除标准
- •Subjects with alcohol use disorder:
- •Withdrawal of the declaration of consent
- •Alcohol consumption on the day of the examination (breath alcohol concentration> 0.3 ‰)
- •Axis I disorder DSM 5 (except alcohol consumption disorder and Nicotine use disorder) within the past 12 months
- •Pharmacotherapy with psychoactive substances within the past 14 days (except for stable doses of non-dopamine-active antidepressants and neuroleptics)
- •Current drug abuse (THC, amphetamine, opiates, Benzodiazepines, barbiturates and cocaine)
- •Not able to communicate with the examiner
- •wearing glasses (without the possibility to wear contact lenses)
- •Parkinson's disease
- •History of withdrawal delirium or seizures
- •Withdrawal symptoms determined via Clinical Institute Withdrawal Assessment for Alcohol Score (Score> 4)
- •Healthy subjects in the control group:
- •Withdrawal of the declaration of consent
- •Fulfillment of> = 1 Alcohol Use Disorder criteria according to DSM-V
- •Alcohol consumption on the day of the examination (breath alcohol concentration> 0.3 ‰)
- •Axis I disorder DSM 5 (except alcohol use disorder and Nicotine use disorder) within the past 12 months
- •Pharmacotherapy with psychoactive substances within the past 14 days (except for stable doses of non-dopamine-active antidepressants and neuroleptics)
- •Current drug abuse (THC, amphetamine, opiates, Benzodiazepines, barbiturates and cocaine)
- •Not able to communicate with the examiner
- •wearing glasses (without the possibility to wear contact lenses)
- •Parkinson's disease
- •History of withdrawal delirium or seizures
- •Withdrawal symptoms determined via Clinical Institute Withdrawal Assessment for Alcohol Score (Score> 4)
研究者
相似试验
已完成
不适用
Investigation of the effect of reward-contingent audiovisual stimuli on decision-making in a virtual gambling game.Healthy probandsF63.0Pathological gamblingDRKS00018922Zentralinstitut für Seelische Gesundheit Mannheim24
终止
不适用
Influence of a behavioural incentive and intensive education on the quality of bowel preparation prior to diagnostic colonoscopiesACTRN12619001198112PA Foundation162
进行中（未招募）
1 期
Study about the response to the administration of a third dose of mRNA-1273 vaccine (COVID19 vaccine Moderna) in renal transplants with immunological failure initial to vaccinatioCOVID19 vaccine in kidney transplant patientsMedDRA version: 23.1Level: LLTClassification code 10084464Term: COVID-19 immunizationSystem Organ Class: 100000004865MedDRA version: 23.1Level: LLTClassification code 10084465Term: COVID-19 vaccinationSystem Organ Class: 100000004865EUCTR2021-002356-37-ESFundació Clinic per a la Recerca Biomèdica (FCRB)80
尚未招募
不适用
Measuring the motivational influences of reward on human motor behaviourBasic science with healthy participants.DRKS00009421eural Control of Movenment LabEidgenössische Technische Hochschule Zürich540
招募中
不适用
PET-study on the role of the reward system in weight loss after bariatric surgeryNL-OMON51338niversitair Medisch Centrum Groningen30